Entrada Therapeutics
ID: 5875876Entrada Therapeutics is a biologics delivered to cytosol founded in 2016.
2
Funding Rounds
$175.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ca**** Nu********** | - | - | - |
| Di*** Do*** | - | - | |
| Ma** Th***** | - | - | |
| Pe*** S. Ki* | - | - | - |
| Ku** Pa**** | - | - | - |
| To** Fo*** | - | - | - |
| Jo** F. Cr***** | - | - | - |
Funding series
Funding Series Analysis
The company Entrada Therapeutics has raised a total of $116m in funding over 2 rounds.
Key Insights:
- Entrada Therapeutics, Inc. funding round, April 2021: $116m
- Entrada Therapeutics funding round, December 2018: $59m
Industries
Entrada Therapeutics is active in the following industries: